← Leaderboards
Roby Paul Bhattacharyya
Massachusetts General Hospital
$4,624,355
Attributed
$5,590,651
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,590,651 · 5
By mechanism
R01$3,265,050 · 1
R21$891,750 · 2
K08$757,672 · 1
R33$676,179 · 1
Top collaborators
- Michael Filbin3 shared
- Nathan I Shapiro3 shared
- Nezihi Murat Karabacak1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael Filbin$2,016,949
- Bob S Carter$9,693,982
- Raymond T Chung$38,306,004
- Marcia B Goldberg$29,817,146
- Hakho Lee$15,122,007
Others in their field
Top investigators on “Transcriptome Sequencing”
- Stacey Gabriel · Massachusetts Institute Of Technology$136,250,146
- Hongkui Zeng · Allen Institute$113,949,516
- Ed Lein · Allen Institute$90,043,218
- Eric S Lander · Whitehead Institute For Biomedical Res$77,457,964
- Richard A Gibbs · Baylor College Of Medicine$55,759,987
- Nenad Sestan · Yale University$55,663,111
Research focus
Transcriptome SequencingResponseSamplingGene ExpressionGenetic TranscriptionTranscriptomicsAntibioticsCellsDiagnosisBloodMortalityMedicalMorbidity - Disease RateCessation Of LifeResistanceBacteriaTranscriptPathogenPatient PopulationDrug ResistanceOverexpressionPositioning AttributeInfectionInsight
Grant awards (13)
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts$676,179
R33 · FY2025 · GM
Novel point-of-care liquid biopsy for early detection of sepsis-associated organ damage$473,937
R21 · FY2025 · AI
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection$652,802
R01 · FY2024 · AI · contact PI
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts$199,629
R21 · FY2024 · GM
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection$649,802
R01 · FY2023 · AI · contact PI
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts$218,184
R21 · FY2023 · GM
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection$657,346
R01 · FY2022 · AI · contact PI
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection$659,282
R01 · FY2021 · AI · contact PI
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection$645,818
R01 · FY2020 · AI · contact PI
Bioinformatic and functional analysis of antibiotic-responsive small non-coding RNAs in bacterial pathogens$196,762
K08 · FY2018 · AI · contact PI
Bioinformatic and functional analysis of antibiotic-responsive small non-coding RNAs in bacterial pathogens$196,762
K08 · FY2017 · AI · contact PI
Bioinformatic and functional analysis of antibiotic-responsive small non-coding RNAs in bacterial pathogens$182,074
K08 · FY2016 · AI · contact PI
Bioinformatic and functional analysis of antibiotic-responsive small non-coding RNAs in bacterial pathogens$182,074
K08 · FY2015 · AI · contact PI